CTGF and chronic kidney fibrosis

Frontiers in Bioscience - Scholar

Volumn 1 S, Issue 1, 2009, Pages 132-141

  Chen, Xin Ming ^a   Qi, Weier ^b   Pollock, Carol A ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

CTGF; Diabetic nephropathy; Epithelial to mesenchymal transition; Renal fibrosis; Review; Tubulointerstitial fibrosis

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CTGF PROTEIN, HUMAN;

CHRONIC DISEASE; FIBROSIS; HUMAN; KIDNEY DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

CHRONIC DISEASE; CONNECTIVE TISSUE GROWTH FACTOR; FIBROSIS; HUMANS; KIDNEY DISEASES; SIGNAL TRANSDUCTION;

EID: 75449084561     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/e13     Document Type: Review

References (94)

1. E. P. Bottinger and M. Bitzer: TGF-beta signaling in renal disease. J Am Soc Nephrol 13, 2600-2600 (2002)
2. L. Yu, W. A. Border, I. Anderson, M. McCourt, Y. Huang and N. A. Noble: Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect. Kidney Int 66, 1774-1774 (2004)
3. H. Ha and H. B. Lee: Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology (Carlton) 10 Suppl, S7-10 (2005) (Pubitemid 41743468)
4. W. Qi, X. Chen, R. E. Gilbert, Y. Zhang, M. Waltham, M. Schache, D. J. Kelly and C. A. Pollock: High glucoseinduced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factorbeta1. Am J Pathol 171, 744-744 (2007)
5. Y. Liu: Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69, 213-213 (2006)
6. M. Ruiz-Ortega, M. Ruperez, V. Esteban, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal and J. Egido: Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21, 16-16 (2006)
7. J. K. Crean, F. Furlong, D. Finlay, D. Mitchell, M. Murphy, B. Conway, H. R. Brady, C. Godson and F. Martin: Connective tissue growth factor (CTGF)/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization. Faseb J 18, 1541-1541 (2004)
8. H. S. Kim, S. R. Nagalla, Y. Oh, E. Wilson, C. T. Roberts, Jr. and R. G. Rosenfeld: Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci U S A 94, 12981-12981 (1997)
9. C. Collet and J. Candy: How many insulin-like growth factor binding proteins? Mol Cell Endocrinol 139, 1-1 (1998)
10. D. H. Yang, H. S. Kim, E. M. Wilson, R. G. Rosenfeld and Y. Oh: Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. J Clin Endocrinol Metab 83, 2593-2593 (1998)
11. C. L. Steffen, D. K. Ball-Mirth, P. A. Harding, N. Bhattacharyya, S. Pillai and D. R. Brigstock: Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cells in vitro. Growth Factors 15, 199-199 (1998)
12. D. R. Brigstock, C. L. Steffen, G. Y. Kim, R. K. Vegunta, J. R. Diehl and P. A. Harding: Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10, 000 forms of connective tissue growth factor. J Biol Chem 272, 20275-20275 (1997)
13. B. L. Riser, M. Denichilo, P. Cortes, C. Baker, J. M. Grondin, J. Yee and R. G. Narins: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 11, 25-25 (2000)
14. D. M. Bradham, A. Igarashi, R. L. Potter and G. R. Grotendorst: Connective tissue growth factor: a cysteinerich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114, 1285-1285 (1991)
15. I. E. Blom, A. J. van Dijk, R. A. de Weger, M. G. Tilanus and R. Goldschmeding: Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms. Mol Pathol 54, 192-192 (2001)
16. C. Fonseca, G. E. Lindahl, M. Ponticos, P. Sestini, E. A. Renzoni, A. M. Holmes, P. Spagnolo, P. Pantelidis, P. Leoni, N. McHugh, C. J. Stock, X. Shi-Wen, C. P. Denton, C. M. Black, K. I. Welsh, R. M. du Bois and D. J. Abraham: A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 357, 1210-1210 (2007)
17. Y. Ito, J. Aten, R. J. Bende, B. S. Oemar, T. J. Rabelink, J. J. Weening and R. Goldschmeding: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53, 853-853 (1998)
18. R. Goldschmeding, J. Aten, Y. Ito, I. Blom, T. Rabelink and J. J. Weening: Connective tissue growth factor: just another factor in renal fibrosis? Nephrol Dial Transplant 15, 296-296 (2000)
19. M. L. Kireeva, B. V. Latinkic, T. V. Kolesnikova, C. C. Chen, G. P. Yang, A. S. Abler and L. F. Lau: Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res 233, 63-63 (1997)
20. T. Nakanishi, Y. Kimura, T. Tamura, H. Ichikawa, Y. Yamaai, T. Sugimoto and M. Takigawa: Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem Biophys Res Commun 234, 206-206 (1997)
21. K. Frazier, S. Williams, D. Kothapalli, H. Klapper and G. R. Grotendorst: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107, 404-404 (1996)
22. L. F. Lau and S. C. Lam: The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248, 44-44 (1999)
23. I. Inoki, T. Shiomi, G. Hashimoto, H. Enomoto, H. Nakamura, K. Makino, E. Ikeda, S. Takata, K. Kobayashi and Y. Okada: Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Faseb J 16, 219-219 (2002)
24. R. A. Dean, G. S. Butler, Y. Hamma-Kourbali, J. Delbe, D. R. Brigstock, J. Courty and C. M. Overall: Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Mol Cell Biol 27, 8454-8454 (2007)
25. D. R. Brigstock: Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61) Angiogenesis 5, 153-153 (2002)
26. J. M. Hughes, E. J. Kuiper, I. Klaassen, P. Canning, A. W. Stitt, J. Van Bezu, C. G. Schalkwijk, C. J. Van Noorden and R. O. Schlingemann: Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia 50, 1089-1089 (2007)
27. M. R. Chintalapudi, M. Markiewicz, N. Kose, V. Dammai, K. J. Champion, R. S. Hoda, M. Trojanowska and T. Hsu: Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells. Carcinogenesis 29, 696-696 (2008)
28. E. Gore-Hyer, D. Shegogue, M. Markiewicz, S. Lo, D. Hazen-Martin, E. L. Greene, G. Grotendorst and M. Trojanowska: TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 283, F707-16 (2002) (Pubitemid 35033958)
29. H. Yokoi, A. Sugawara, M. Mukoyama, K. Mori, H. Makino, T. Suganami, T. Nagae, K. Yahata, Y. Fujinaga, I. Tanaka and K. Nakao: Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis. Am J Kidney Dis 38, S134-8 (2001)
30. A. Igarashi, H. Okochi, D. M. Bradham and G. R. Grotendorst: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4, 637-637 (1993)
31. J. G. Abreu, N. I. Ketpura, B. Reversade and E. M. De Robertis: Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4, 599-599 (2002)
32. G. R. Grotendorst, H. Okochi and N. Hayashi: A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7, 469-469 (1996)
33. A. Leask, S. Sa, A. Holmes, X. Shiwen, C. M. Black and D. J. Abraham: The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol Pathol 54, 180-180 (2001)
34. A. Leask, A. Holmes, C. M. Black and D. J. Abraham: Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 278, 13008-13008 (2003)
35. A. Holmes, D. J. Abraham, S. Sa, X. Shiwen, C. M. Black and A. Leask: CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 276, 10594-10594 (2001)
36. Y. Chen, I. E. Blom, S. Sa, R. Goldschmeding, D. J. Abraham and A. Leask: CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 62, 1149-1149 (2002)
37. N. A. Wahab, B. S. Weston and R. M. Mason: Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2. Exp Cell Res 307, 305-305 (2005)
38. M. K. Phanish, N. A. Wahab, P. Colville-Nash, B. M. Hendry and M. E. Dockrell: The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J 393, 601-601 (2006)
39. I. E. Blom, R. Goldschmeding and A. Leask: Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 21, 473-473 (2002)
40. A. Keil, I. E. Blom, R. Goldschmeding and H. D. Rupprecht: Nitric oxide down-regulates connective tissue growth factor in rat mesangial cells. Kidney Int 62, 401-401 (2002)
41. N. A. Wahab, B. S. Weston and R. M. Mason: Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J Am Soc Nephrol 16, 340-340 (2005)
42. W. Qi, X. Chen, S. Twigg, Y. Zhang, R. E. Gilbert, D. J. Kelly and C. A. Pollock: The differential regulation of Smad7 in kidney tubule cells by connective tissue growth factor and transforming growth factor-beta1. Nephrology (Carlton) 12, 267-267 (2007)
43. W. Qi, S. Twigg, X. Chen, T. S. Polhill, P. Poronnik, R. E. Gilbert and C. A. Pollock: Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis. Am J Physiol Renal Physiol 288, F800-9 (2005) (Pubitemid 40381749)
44. K. Kikuchi, T. Kadono, H. Ihn, S. Sato, A. Igarashi, H. Nakagawa, K. Tamaki and K. Takehara: Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta 1. J Invest Dermatol 105, 128-128 (1995)
45. T. Nishida, T. Nakanishi, T. Shimo, M. Asano, T. Hattori, T. Tamatani, K. Tezuka and M. Takigawa: Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8) Biochem Biophys Res Commun 247, 905-905 (1998)
46. T. Nishida, T. Nakanishi, M. Asano, T. Shimo and M. Takigawa: Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol 184, 197-197 (2000)
47. R. Gao and D. R. Brigstock: Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 27, 214-214 (2003)
48. Y. Chen, P. Segarini, F. Raoufi, D. Bradham and A. Leask: Connective tissue growth factor is secreted through the Golgi and is degraded in the endosome. Exp Cell Res 271, 109-109 (2001)
49. M. Yang, H. Huang, J. Li, D. Li and H. Wang: Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation. Faseb J 18, 1920-1920 (2004)
50. N. A. Wahab, N. Yevdokimova, B. S. Weston, T. Roberts, X. J. Li, H. Brinkman and R. M. Mason: Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 359, 77-77 (2001)
51. W. C. Burns, P. Kantharidis and M. C. Thomas: The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 185, 222-222 (2007)
52. N. Wahab, D. Cox, A. Witherden and R. M. Mason: Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1) Biochem J 406, 131-131 (2007)
53. J. K. Crean, F. Furlong, D. Mitchell, E. McArdle, C. Godson and F. Martin: Connective tissue growth factor/CCN2 stimulates actin disassembly through Akt/protein kinase B-mediated phosphorylation and cytoplasmic translocation of p27 (Kip-1) Faseb J 20, 1712-1712 (2006)
54. D. H. Hryciw, Y. Wang, O. Devuyst, C. A. Pollock, P. Poronnik and W. B. Guggino: Cofilin interacts with ClC-5 and regulates albumin uptake in proximal tubule cell lines. J Biol Chem 278, 40169-40169 (2003)
55. R. Masterson, K. Kelynack, T. Hewitson and G. Becker: Effect of inhibition of farnesylation and geranylgeranylation on renal fibrogenesis in vitro. Nephron Exp Nephrol 102, e19-29 (2006) (Pubitemid 43250935)
56. M. Ruperez, R. Rodrigues-Diez, L. M. Blanco-Colio, E. Sanchez-Lopez, J. Rodriguez-Vita, V. Esteban, G. Carvajal, J. J. Plaza, J. Egido and M. Ruiz-Ortega: HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways. Hypertension 50, 377-377 (2007)
57. V. Haydont, B. L. Riser, J. Aigueperse and M. C. Vozenin-Brotons: Specific signals involved in the longterm maintenance of radiation-induced fibrogenic differentiation: a role for CCN2 and low concentration of TGF {beta}1. Am J Physiol Cell Physiol (2008)
58. G. F. Strippoli, S. D. Navaneethan, D. W. Johnson, V. Perkovic, F. Pellegrini, A. Nicolucci and J. C. Craig: Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. Bmj 336, 645-645 (2008)
59. H. Yokoi, M. Mukoyama, A. Sugawara, K. Mori, T. Nagae, H. Makino, T. Suganami, K. Yahata, Y. Fujinaga, I. Tanaka and K. Nakao: Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol 282, F933-42 (2002) (Pubitemid 34654499)
60. P. Roestenberg, F. A. van Nieuwenhoven, J. A. Joles, C. Trischberger, P. P. Martens, N. Oliver, J. Aten, J. W. Hoppener and R. Goldschmeding: Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol 290, F1344-54 (2006) (Pubitemid 43830759)
61. S. Wang, M. Denichilo, C. Brubaker and R. Hirschberg: Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 60, 96-96 (2001)
62. T. Kobayashi, H. Okada, T. Inoue, Y. Kanno and H. Suzuki: Tubular expression of connective tissue growth factor correlates with interstitial fibrosis in type 2 diabetic nephropathy. Nephrol Dial Transplant 21, 548-548 (2006)
63. W. C. Burns, S. M. Twigg, J. M. Forbes, J. Pete, C. Tikellis, V. Thallas-Bonke, M. C. Thomas, M. E. Cooper and P. Kantharidis: Connective tissue growth factor plays an important role in advanced glycation end productinduced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 17, 2484-2484 (2006)
64. W. Qi, X. Chen, P. Poronnik and C. A. Pollock: Transforming growth factor-beta/connective tissue growth factor axis in the kidney. Int J Biochem Cell Biol 40, 9-9 (2008)
65. C. Zhang, Z. Zhu and A. Deng: The effect of connective tissue growth factor on human renal tubular epithelial cell transdifferentiation. J Huazhong Univ Sci Technolog Med Sci 24, 350-350 (2004)
66. C. Zhang, X. Meng, Z. Zhu, J. Liu and A. Deng: Connective tissue growth factor regulates the key events in tubular epithelial to myofibroblast transition in vitro. Cell Biol Int 28, 863-863 (2004)
67. C. Zhang, X. F. Meng, Z. H. Zhu, X. Yang and A. G. Deng: Role of connective growth factor in plasminogen activator inhibitor-1 and fibronectin expression induced by transforming growth factor beta1 in renal tubular cells. Chin Med J (Engl) 117, 990-990 (2004)
68. C. Zhang, X. Meng, Z. Zhu, X. Yang and A. Deng: Role of connective tissue growth factor in renal tubular epithelial-myofibroblast transdifferentiation and extracellular matrix accumulation in vitro. Life Sci 75, 367-367 (2004)
69. H. Yokoi, M. Mukoyama, T. Nagae, K. Mori, T. Suganami, K. Sawai, T. Yoshioka, M. Koshikawa, T. Nishida, M. Takigawa, A. Sugawara and K. Nakao: Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15, 1430-1430 (2004)
70. H. Okada, T. Kikuta, T. Kobayashi, T. Inoue, Y. Kanno, M. Takigawa, T. Sugaya, J. B. Kopp and H. Suzuki: Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol 16, 133-133 (2005)
71. W. Qi, X. Chen, S. Twigg, T. S. Polhill, R. E. Gilbert and C. A. Pollock: Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells. Kidney Int 69, 989-989 (2006)
72. W. Qi, X. Chen, J. Holian, E. Mreich, S. Twigg, R. E. Gilbert and C. A. Pollock: Transforming growth factorbeta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells. Am J Physiol Renal Physiol 291, F1070-7 (2006) (Pubitemid 44772040)
73. W. Qi, X. Chen, T. S. Polhill, S. Sumual, S. Twigg, R. E. Gilbert and C. A. Pollock: TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factorindependent pathway. Am J Physiol Renal Physiol 290, F703-9 (2006) (Pubitemid 43724973)
74. H. Y. Lan: Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 12, 25-25 (2003)
75. E. G. Neilson: Mechanisms of disease: Fibroblasts-a new look at an old problem. Nat Clin Pract Nephrol 2, 101-101 (2006)
76. M. S. Simonson: Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int 71, 846-846 (2007)
77. M. Iwano, D. Plieth, T. M. Danoff, C. Xue, H. Okada and E. G. Neilson: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110, 341-341 (2002)
78. Y. Liu: Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15, 1-1 (2004)
79. N. A. Wahab and R. M. Mason: A critical look at growth factors and epithelial-to-mesenchymal transition in the adult kidney. Interrelationships between growth factors that regulate EMT in the adult kidney. Nephron Exp Nephrol 104, e129-34 (2006) (Pubitemid 44885059)
80. H. Benchabane and J. L. Wrana: GATA-and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations. Mol Cell Biol 23, 6646-6646 (2003)
81. J. Yang, C. Dai and Y. Liu: A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol 16, 68-68 (2005)
82. M. Zeisberg, J. Hanai, H. Sugimoto, T. Mammoto, D. Charytan, F. Strutz and R. Kalluri: BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9, 964-964 (2003)
83. B. L. Riser, P. Cortes, M. DeNichilo, P. V. Deshmukh, P. S. Chahal, A. K. Mohammed, J. Yee and D. Kahkonen: Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int 64, 451-451 (2003)
84. T. Q. Nguyen, L. Tarnow, S. Andersen, P. Hovind, H. H. Parving, R. Goldschmeding and F. A. van Nieuwenhoven: Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 29, 83-83 (2006)
85. S. Andersen, F. A. van Nieuwenhoven, L. Tarnow, P. Rossing, K. Rossing, L. Wieten, R. Goldschmeding and H. H. Parving: Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy. Kidney Int 67, 2325-2325 (2005)
86. B. C. Liu, J. Sun, Q. Chen, K. L. Ma, X. Z. Ruan and A. O. Phillips: Role of connective tissue growth factor in mediating hypertrophy of human proximal tubular cells induced by angiotensin II. Am J Nephrol 23, 429-429 (2003)
87. B. C. Liu, L. Chen, J. Sun, H. Q. Huang, K. L. Ma, H. Liu, D. G. Liu and X. L. Zhang: Connective tissue growth factor-mediated angiotensin II-induced hypertrophy of proximal tubular cells. Nephron Exp Nephrol 103, e16-26 (2006)
88. M. Ruperez, M. Ruiz-Ortega, V. Esteban, O. Lorenzo, S. Mezzano, J. J. Plaza and J. Egido: Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol 163, 1937-1937 (2003)
89. M. Ruperez, O. Lorenzo, L. M. Blanco-Colio, V. Esteban, J. Egido and M. Ruiz-Ortega: Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 108, 1499-1499 (2003)
90. N. de las Heras, M. Ruiz-Ortega, M. Ruperez, D. Sanz-Rosa, M. Miana, P. Aragoncillo, S. Mezzano, V. Lahera, J. Egido and V. Cachofeiro: Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II. J Renin Angiotensin Aldosterone Syst 7, 192-192 (2006)
91. G. Jerums, S. Panagiotopoulos, J. Forbes, T. Osicka and M. Cooper: Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Arch Biochem Biophys 419, 55-55 (2003)
92. J. M. Forbes, M. E. Cooper, M. D. Oldfield and M. C. Thomas: Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 14, S254-8 (2003) (Pubitemid 36903936)
93. G. Zhou, C. Li and L. Cai: Advanced glycation endproducts induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol 165, 2033-2033 (2004)
94. C. I. Lee, J. Y. Guh, H. C. Chen, W. C. Hung, Y. L. Yang and L. Y. Chuang: Advanced glycation end-productinduced mitogenesis and collagen production are dependent on angiotensin II and connective tissue growth factor in NRK-49F cells. J Cell Biochem 95, 281-281 (2005)